BRIEF published on 04/22/2026 at 22:05, 1 month 24 days ago Inventiva Bolsters Executive Team as It Nears Key Phase 3 Data Milestone Phase 3 Trial Lanifibranor Leadership Expansion MASH Treatment Inventiva Biopharmaceutical
PRESS RELEASE published on 04/22/2026 at 22:00, 1 month 24 days ago Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor Inventiva strengthens leadership team with new key hires for lanifibranor Phase 3 data readout, bolstering expertise in finance, legal, and HR to drive growth and commercialization Growth Leadership Team Phase 3 Inventiva Lanifibranor
BRIEF published on 04/08/2026 at 22:05, 2 months 8 days ago Inventiva Submits 2025 Financial Reports to AMF and SEC Inventiva 2025 Financial Reports MASH Treatments Biopharmaceutical Developments AMF And SEC Filings
BRIEF published on 04/08/2026 at 22:05, 2 months 8 days ago Inventiva files its Universal Registration Document and its 2025 Annual Report Annual Report Biopharmaceutical Registration Document Inventiva MASH
PRESS RELEASE published on 04/08/2026 at 22:00, 2 months 8 days ago Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F Inventiva files 2025 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, focusing on MASH therapies Biopharmaceutical 2025 Filing Inventiva MASH
BRIEF published on 04/02/2026 at 15:55, 2 months 15 days ago JP Morgan Chase & Co. crosses the thresholds for participation in INVENTIVA Voting Rights Threshold Crossing JP Morgan Inventiva Equity Swap
BRIEF published on 03/30/2026 at 22:16, 2 months 17 days ago Inventiva Announces 2025 Financial Results and Business Update Public Offering Cash Reserves Inventiva Lanifibranor 2025 Financial Results
PRESS RELEASE published on 03/30/2026 at 22:11, 2 months 17 days ago Inventiva reports 2025 full year results and provides a business update Inventiva reports 2025 full year results with €4.5 million revenues, provides business update on strategic pipeline, clinical trials, and financial performance Financial Performance Business Update Clinical Trials Inventiva 2025 Results
BRIEF published on 03/23/2026 at 22:05, 2 months 24 days ago Inventiva Announces Schedule for 2025 Financial Results Financial Results Conference Call Biopharmaceutical Inventiva MASH
BRIEF published on 03/23/2026 at 22:05, 2 months 24 days ago Inventiva announces its 2025 annual financial results Financial Results Conference Call Investors Steatohepatitis Oral Therapy
Published on 06/17/2026 at 14:30, 1 hour 38 minutes ago Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 2 hours 8 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 14:00, 2 hours 8 minutes ago Interpretation of High-Resolution Geophysics at Music Valley HREE Project
Published on 06/17/2026 at 14:00, 2 hours 8 minutes ago AEONIAN Completes Drilling at Jake Target and Advances District-Scale Copper-Silver Model, Koocanusa Project, BC
Published on 06/17/2026 at 15:54, 14 minutes ago CANCOM SE: Annual General Meeting approves all proposed resolutions by a large majority
Published on 06/17/2026 at 15:38, 29 minutes ago United Terra Enterprises PLC Expands Renewable Portfolio via Strategic Alternative Energy Joint Venture Company in Ghana
Published on 06/17/2026 at 15:16, 52 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/17/2026 at 08:45, 7 hours 23 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 4 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 17 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 1 day 21 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
Published on 06/15/2026 at 18:32, 1 day 21 hours ago Edenred strengthens its electric charging offering with the acquisition of The Mobility House Solutions
